HemaSphere
(Aug 2023)
P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T(4;14)-POSITIVE MULTIPLE MYELOMA
- Jiasi Zhang,
- Yuxi Liu,
- Liping Zuo,
- Fengjuan Fan,
- Han Yan,
- Fei Zhao,
- Bo Zhang,
- Yu Hu,
- Chunyan Sun
Affiliations
- Jiasi Zhang
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Yuxi Liu
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Liping Zuo
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Fengjuan Fan
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Han Yan
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Fei Zhao
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Bo Zhang
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Yu Hu
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- Chunyan Sun
- 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hematology, Wuhan, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000970132.53249.f9
- Journal volume & issue
-
Vol. 7
p.
e53249f9
WeChat QR code